GCM
MRK icon

Gladius Capital Management’s Merck MRK Stock Holding History

Gladius Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$902K Buy
+7,500
New +$866K 0.04% 93
2025
Q2 		– Sell
-11,848
Closed -$1.06M – 73
2025
Q1 		$1.06M Sell
11,848
-291
-2% -$27.2K 0.28% 57
2024
Q4 		$1.21M Sell
12,139
-2,724
-18% -$281K 0.13% 70
2024
Q3 		$1.69M Buy
14,863
+9,246
+165% +$1.1M 0.2% 55
2024
Q2 		$695K Buy
5,617
+4,292
+324% +$553K 0.09% 95
2024
Q1 		$175K Buy
+1,325
New +$163K 0.06% 130
2023
Q4 		– Sell
-35,938
Closed -$3.73M – 379
2023
Q3 		$3.7M Buy
+35,938
New +$3.87M 0.15% 96
2023
Q2 		– Sell
-20,638
Closed -$2.34M – 430
2023
Q1 		$2.2M Buy
20,638
+17,955
+669% +$1.94M 0.13% 81
2022
Q4 		$298K Sell
2,683
-8,223
-75% -$841K 0.02% 121
2022
Q3 		$940K Buy
10,906
+9,343
+598% +$834K 0.04% 111
2022
Q2 		$143K Buy
1,563
+896
+134% +$79.4K 0.01% 172
2022
Q1 		$55K Sell
667
-1,798
-73% -$142K ﹤0.01% 262
2021
Q4 		$189K Buy
+2,465
New +$196K 0.02% 187
2021
Q2 		– Sell
-25,472
Closed -$1.89M – 158
2021
Q1 		$1.87M Buy
25,472
+15,586
+158% +$1.15M 0.07% 123
2020
Q4 		$772K Buy
9,886
+6,350
+180% +$486K 0.04% 148
2020
Q3 		$280K Buy
+3,536
New +$277K 0.03% 155
2020
Q2 		– Sell
-12,022
Closed -$883K – 89
2020
Q1 		$883K Buy
+12,022
New +$945K 0.09% 98
2019
Q4 		– Sell
-64,221
Closed -$5.27M – 194
2019
Q3 		$5.16M Buy
64,221
+14,207
+28% +$1.14M 0.24% 81
2019
Q2 		$4.04M Buy
50,014
+25,263
+102% +$1.93M 0.24% 43
2019
Q1 		$1.96M Sell
24,751
-39,036
-61% -$2.92M 0.11% 89
2018
Q4 		$4.65M Buy
63,787
+60,934
+2,136% +$4.3M 0.23% 73
2018
Q3 		$193K Sell
2,853
-8,464
-75% -$539K 0.02% 73
2018
Q2 		$655 Buy
+11,317
New +$638K 0.07% 61

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Gladius Capital Management's MRK Position: Q1 2026 in Review

Gladius Capital Management opened a new position in Merck (MRK) in Q1 2026: 7,500 shares worth $902K. The stake represents 0.04% of the portfolio and ranks #93 among its holdings. This is a return to the name: Gladius Capital Management previously reported a position in MRK as recently as Q1 2025.

Gladius Capital Management first reported a position in MRK in Q2 2018 and has held it in 23 quarters since. The position peaked at $5.16M in Q3 2019. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Gladius Capital Management held 7,500 shares of Merck worth $902K as of Q1 2026.
  • Merck was a new Gladius Capital Management position in Q1 2026.
  • Merck made up 0.04% of Gladius Capital Management's portfolio in Q1 2026, its #93 holding.
  • Gladius Capital Management first reported a position in Merck in Q2 2018 and has held it in 23 quarters since.
  • Gladius Capital Management's Merck position peaked at $5.16M in Q3 2019.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Gladius Capital Management's 13F filing for Q1 2026, filed 7 May 2026.